Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawa, M. I.
Right arrow Articles by Leslie, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawa, M. I.
Right arrow Articles by Leslie, R. D.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 23, Issue 2 228-233, Copyright © 2000 by American Diabetes Association

ARTICLES

Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality

MI Hawa, D Fava, F Medici, YJ Deng, AL Notkins, G De Mattia and RD Leslie
Department of Diabetes and Metabolism, St. Bartholomew's Hospital, London, UK. m.i.hawa@mds.gmw.ac.uk

OBJECTIVE: To determine the isotypes and clonality of antibodies to GAD (GADA) and IA-2 (IA-2A) in patients with type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied the following consecutive series of patients who attended a diabetes center for antibodies to GADA and IA-2A: 52 newly diagnosed type 1 diabetic patients, 199 type 2 diabetic patients, 200 control patients, and a cohort of 34 nondiabetic identical twins of patients with type 1 diabetes (15 of whom developed diabetes) who were followed prospectively. RESULTS: GADA or IA-2A were detected in 37 (71%) type 1 diabetic patients compared with only 10 (5%) type 2 diabetic patients (P<0.0001). Both GAD and IA-2 antibodies, regardless of the type of diabetes, were usually subclass restricted to IgG1 and were polyclonal. IgM, IgG3, and IgE isotypes were also detected, but all isotypes of GADA and IA-2A were less prevalent than IgG1 (P<0.017 for either antibody). There was no evidence of spreading or switching of isotypes before the onset of type 1 diabetes. CONCLUSIONS: These observations suggest that the pathogenesis of antigen-specific antibodies in type 1 and type 2 diabetes is similar and probably involves a chronic nonrandom antigen-driven polyclonal B-cell activation that is consistent with a Th1-type immune response.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
A. Makinen, T. Harkonen, J. Ilonen, M. Knip, and the Finnish Pediatric Diabetes Register
Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
Eur. J. Endocrinol., July 1, 2008; 159(1): 19 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. de Leiva, D. Mauricio, and R. Corcoy
Diabetes-Related Autoantibodies and Gestational Diabetes
Diabetes Care, July 1, 2007; 30(Supplement_2): S127 - S133.
[Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. S Ronkainen, S. Hoppu, S. Korhonen, S. Simell, R. Veijola, J. Ilonen, O. Simell, and M. Knip
Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.
Eur. J. Endocrinol., October 1, 2006; 155(4): 633 - 642.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. S Ronkainen, T. Harkonen, J. Perheentupa, and M. Knip
Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and/or type 1 diabetes
Eur. J. Endocrinol., December 1, 2005; 153(6): 901 - 906.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark
Autoantibodies in Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S52 - S61.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Achenbach, K. Warncke, J. Reiter, H. E. Naserke, A. J.K. Williams, P. J. Bingley, E. Bonifacio, and A.-G. Ziegler
Stratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics
Diabetes, February 1, 2004; 53(2): 384 - 392.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Q. Purnell, R. K. Dev, M. W. Steffes, P. A. Cleary, J. P. Palmer, I. B. Hirsch, J. E. Hokanson, and J. D. Brunzell
Relationship of Family History of Type 2 Diabetes, Hypoglycemia, and Autoantibodies to Weight Gain and Lipids With Intensive and Conventional Therapy in the Diabetes Control and Complications Trial
Diabetes, October 1, 2003; 52(10): 2623 - 2629.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Borg, A. Gottsater, P. Fernlund, and G. Sundkvist
A 12-Year Prospective Study of the Relationship Between Islet Antibodies and {beta}-Cell Function At and After the Diagnosis in Patients With Adult-Onset Diabetes
Diabetes, June 1, 2002; 51(6): 1754 - 1762.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Pozzilli and U. Di Mario
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult): Definition, characterization, and potential prevention
Diabetes Care, August 1, 2001; 24(8): 1460 - 1467.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.